Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000950170-25-104016

Options or other derivatives

  • Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rosiello Robert L. Director 2025-08-05 Grant or award · Stock Option (right to buy) +10,000 10,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…